Taivex Therapeutics Corporation

17F, 3, Park St., Taipei City, Taipei, Taiwan

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

100.0%

Trial Status Distribution

Completed

40.0%

Recruiting

40.0%

Terminated

20.0%

Clinical Trials

Trials sponsored by this organization (5)

Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors

Phase 1

Recruiting

interventional

Dec 202130 participants

Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors

Phase 1

Recruiting

interventional

Jun 202140 participants

Safety and Tolerability Study for T-1101 (Tosylate) Capsules to Treat Advanced Refractory Solid Tumors

Phase 1

Completed

interventional

Jan 202124 participants

An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors

Phase 1

Completed

interventional

Sep 20173 participants

Safety and Tolerability Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors

Phase 1

Terminated

interventional

Sep 201721 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations